TD Cowen Reiterates Buy Rating on TransMedics Group (TMDX)
Tweet Send to a Friend
TD Cowen analyst Joshua Jennings reiterated a Buy rating and $170.00 price target on TransMedics Group (NASDAQ: TMDX).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
